USANA Health Sciences posts mixed Q1 results, strong guidance

Published 22/04/2025, 21:46
USANA Health Sciences posts mixed Q1 results, strong guidance

NEW YORK - USANA Health Sciences, Inc. (NYSE:USNA) reported mixed first quarter results, with revenue beating expectations but earnings per share falling short of analyst estimates.

The nutritional supplement company posted adjusted earnings per share of $0.73, missing the consensus estimate of $0.80. Revenue came in at $250 million, surpassing analyst projections of $243.15 million and representing 10% year-over-year growth.

USANA’s direct selling business saw net sales decline 6.9% year-over-year to $210.5 million. However, this was offset by $37.1 million in revenue from Hiya, the children’s health and wellness company USANA acquired a majority stake in last year.

"We are seeing encouraging signs in our direct sales business with net sales and Active Customers growing modestly on a sequential basis for the second consecutive quarter," said Jim Brown, President and CEO.

For fiscal year 2025, USANA reiterated its outlook, forecasting revenue of $920 million to $1 billion and adjusted EPS of $2.35 to $3.00. The midpoint of the revenue guidance range is slightly above the current analyst consensus of $941.6 million.

"While the global macroeconomic environment has become less certain since the beginning of the year due to volatility in international trade, tariffs, and consumer sentiment, the underlying demand for our products has remained strong," Brown added.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.